CSIMarket
 


Lakeland Industries Inc   (LAKE)
Other Ticker:  
 

Lakeland Industries Inc 's Leverage Ratio

LAKE's quarterly Leverage Ratio and Total Liabilities, Equity growth




LAKE Leverage Ratio (Oct 31 2022)
III. Quarter
(Jul 31 2022)
II. Quarter
(Apr 30 2022)
I. Quarter
(Jan 31 2022)
IV. Quarter
(Oct 31 2021)
III. Quarter
Y / Y Equity Change -6.8 % -3.32 % -2.03 % 10.1 % 23.29 %
Y / Y Total Liabilities Change -0.43 % 14.77 % 1.01 % -15.77 % -2.98 %
Leverage Ratio MRQ 0.15 0.17 0.14 0.13 0.14
Overall Ranking # 379 # 385 # 0 # 0 # 511
Seq. Equity Change -1.88 % -3 % -0.25 % -1.83 % 1.78 %
Seq. Total Liabilities Change -13.56 % 14.38 % 13.73 % -11.44 % -0.37 %



Leverage Ratio third quarter 2022 Comment
Due to repayements of liabilities of -13.56% Lakeland Industries Inc improved Leverage Ratio in third quarter 2022 to 0.15, below company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2022, 45 other companies have achieved lower Leverage Ratio than Lakeland Industries Inc . While Leverage Ratio total ranking has improved so far to 379, from total ranking in previous quarter at 385.

Explain Leverage Ratio?
Who are LAKE Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 46
Healthcare Sector # 209
Overall Market # 379


Leverage Ratio Statistics
High Average Low
0.87 0.35 0.13
(Jul 31 2014)   (Jan 31 2022)




Financial Statements
Lakeland Industries Inc 's Equity $ 119 Millions Visit LAKE's Balance sheet
Lakeland Industries Inc 's Total Liabilities $ 18 Millions Visit LAKE's Balance sheet
Source of LAKE's Sales Visit LAKE's Sales by Geography


Cumulative Lakeland Industries Inc 's Leverage Ratio

LAKE's Leverage Ratio for the trailling 12 Months

LAKE Leverage Ratio

(Oct 31 2022)
III. Quarter
(Jul 31 2022)
II. Quarter
(Apr 30 2022)
I. Quarter
(Jan 31 2022)
IV. Quarter
(Oct 31 2021)
III. Quarter
Y / Y Equity TTM Growth -6.8 % -3.32 % -2.03 % 10.1 % 23.29 %
Y / Y Total Liabilities TTM Growth -0.43 % 14.77 % 1.01 % -15.77 % -2.98 %
Leverage Ratio TTM 0.15 0.14 0.14 0.14 0.15
Total Ranking TTM # 343 # 390 # 375 # 413 # 369
Seq. Equity TTM Growth -1.88 % -3 % -0.25 % -1.83 % 1.78 %
Seq. Total Liabilities TTM Growth -13.56 % 14.38 % 13.73 % -11.44 % -0.37 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of -13.56% in III. Quarter, Leverage Ratio improved to 0.15, below Lakeland Industries Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 42 other companies have achieved lower Leverage Ratio than Lakeland Industries Inc . While total ranking remained unchanged compare to previous quarter at no. 343.

Explain Leverage Ratio?
Who are LAKE Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 199
Within the Market # 343


TTM Leverage Ratio Statistics
High Average Low
0.83 0.3 0.14
(June 30. 2014)   (Jan 31 2022)




Companies with similar Leverage Ratio in the quarter ending Oct 31 2022, within Biotechnology & Pharmaceuticals Industry Leverage RatioOct 31 2022 MRQ Total LiabilitiesOct 31 2022 MRQ Equity
Cue Health Inc   0.40 $ 235.076  Millions$ 589.960  Millions
Heska Corporation  0.40 $ 162.168  Millions$ 407.899  Millions
Vericel Corporation  0.39 $ 70.180  Millions$ 177.837  Millions
Avanos Medical Inc   0.39 $ 498.300  Millions$ 1,263.500  Millions
Edwards Lifesciences Corporation  0.39 $ 2,420.400  Millions$ 6,217.800  Millions
Neurocrine Biosciences Inc   0.39 $ 598.800  Millions$ 1,544.600  Millions
Surface Oncology Inc   0.39 $ 43.454  Millions$ 112.819  Millions
Vicarious Surgical Inc   0.38 $ 41.723  Millions$ 108.952  Millions
Tscan Therapeutics Inc   0.38 $ 43.970  Millions$ 116.658  Millions
Tcr2 Therapeutics Inc   0.37 $ 74.377  Millions$ 198.550  Millions
Cognition Therapeutics inc   0.36 $ 14.237  Millions$ 39.320  Millions
Black Diamond Therapeutics Inc   0.35 $ 47.185  Millions$ 133.231  Millions
Senti Biosciences Inc   0.35 $ 49.098  Millions$ 140.343  Millions
Milestone Scientific Inc   0.35 $ 3.891  Millions$ 11.181  Millions
Sqz Biotechnologies Company  0.35 $ 23.830  Millions$ 68.574  Millions
Renovacor Inc   0.35 $ 14.793  Millions$ 42.708  Millions
Sanara Medtech Inc   0.35 $ 15.452  Millions$ 44.648  Millions
Aligos Therapeutics Inc   0.34 $ 42.056  Millions$ 122.013  Millions
Inogen Inc   0.34 $ 118.742  Millions$ 350.842  Millions
Lifeloc Technologies Inc   0.34 $ 2.072  Millions$ 6.178  Millions
Repligen Corp  0.33 $ 614.267  Millions$ 1,835.109  Millions
Orion Energy Systems Inc   0.33 $ 20.134  Millions$ 60.975  Millions
Biomerica Inc   0.33 $ 2.728  Millions$ 8.322  Millions
Myriad Genetics Inc   0.32 $ 295.400  Millions$ 916.600  Millions
Avrobio Inc   0.32 $ 31.407  Millions$ 98.090  Millions
Inmune Bio Inc   0.32 $ 20.094  Millions$ 63.706  Millions
Polarityte Inc   0.31 $ 5.202  Millions$ 16.943  Millions
Ginkgo Bioworks Holdings Inc   0.30 $ 435.959  Millions$ 1,439.736  Millions
Applied Uv Inc   0.30 $ 7.725  Millions$ 25.842  Millions
Fusion Pharmaceuticals Inc   0.29 $ 53.920  Millions$ 183.142  Millions

Date modified: 2022-12-09T16:32:30+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMAZ's Profile

Stock Price

AMAZ's Financials

Business Description

Fundamentals

Charts & Quotes

AMAZ's News

Suppliers

AMAZ's Competitors

Customers & Markets

Economic Indicators

AMAZ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071